
(AGENPARL) – SILVER SPRING mar 30 maggio 2023 To allow for earlier approval of drugs that treat serious conditions and fill an unmet medical need based on a surrogate endpoint
Fonte/Source: http://www.fda.gov/drugs/nda-and-bla-approvals/accelerated-approval-program